Original Literature | Model OverView |
---|---|
Publication
Title
Calcium signaling in lymphocytes.
Affiliation
Department of Pathology, Harvard Medical School, Immune Disease Institute,Boston, MA 02115, USA.
Abstract
In cells of the immune system, calcium signals are essential for diversecellular functions including differentiation, effector function, and genetranscription. After the engagement of immunoreceptors such as T-cell and B-cellantigen receptors and the Fc receptors on mast cells and NK cells, theintracellular concentration of calcium ions is increased through the sequentialoperation of two interdependent processes: depletion of endoplasmic reticulumCa(2+) stores as a result of binding of inositol trisphosphate (IP(3)) to IP(3)receptors, followed by 'store-operated' Ca(2+) entry through plasma membraneCa(2+) channels. In lymphocytes, mast cells and other immune cell types,store-operated Ca(2+) entry through specialized Ca(2+) release-activated calcium(CRAC) channels constitutes the major pathway of intracellular Ca(2+) increase.A recent breakthrough in our understanding of CRAC channel function is theidentification of stromal interaction molecule (STIM) and ORAI, two essentialregulators of CRAC channel function. This review focuses on the signalingpathways upstream and downstream of Ca(2+) influx (the STIM/ORAI andcalcineurin/NFAT pathways, respectively).
PMID
18515054
|
Entity
Ras family
--
MO000000003
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m41
10
infinite
0
TRANSPATH | MO000000003 |
--
NF-kappaB{active}
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m28
10
infinite
0
TRANSPATH | MO000000058 |
--
calmodulin:(Ca)4
--
MO000016711
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1665
10
infinite
0
TRANSPATH | MO000016711 |
--
calcineurin
--
MO000016724
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1676
10
infinite
0
TRANSPATH | MO000016724 |
--
MAPK{active}
--
MO000016894
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1812
10
infinite
0
TRANSPATH | MO000016894 |
--
CREB
--
MO000017189
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2057
10
infinite
0
InterPro | IPR003102 |
TRANSPATH | MO000017189 |
--
PLCgamma1{p}
--
MO000038437
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16647
10
infinite
0
TRANSPATH | MO000038437 |
--
STIM1
--
MO000062470
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m37358
10
infinite
0
TRANSPATH | MO000062470 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
antigen Ig:MHC peptide:BCR
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m12
0
infinite
0
--
--
e14
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToInternalSideOfMembrane_
--
--
--
csml-variable:Double
m14
0
infinite
0
--
--
e15
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulumLumen
--
--
--
csml-variable:Double
m15
0
infinite
0
--
--
e16
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_Membrane_
--
--
--
csml-variable:Double
m16
0
infinite
0
--
--
e17
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToExternalSideOfMembrane_
--
--
--
csml-variable:Double
m17
0
infinite
0
--
--
e18
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum
--
--
--
csml-variable:Double
m18
0
infinite
0
--
--
e19
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_IntegralToMembrane_
--
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
ca2+
--
e20
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
ca2+
--
e21
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
CRAC channels
--
e22
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
ca2+
--
e23
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
PKC{active}
--
e25
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m25
10
infinite
0
TRANSPATH | MO000000104 |
--
CREB{active}
--
e27
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m27
10
infinite
0
InterPro | IPR003102 |
TRANSPATH | MO000017189 |
--
NFAT{p}
--
e29
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
NFAT{active}
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
NFAT{active}
--
e31
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
CAMK
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
csml-variable:Double
m34
0
infinite
0
--
MEF2
--
e34
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
MEF2{active}
--
e35
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
DNA
--
e36
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m37
0
infinite
0
--
NFAT:Fos:Jun
--
e37
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m38
0
infinite
0
--
activation associated genes
--
e38
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m39
0
infinite
0
--
Ras family{active}
--
e39
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m42
10
infinite
0
TRANSPATH | MO000000003 |
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
RasGEF
--
e40
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m43
0
infinite
0
--
RasGAP1
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m40
0
infinite
0
--
CAPRI
--
e42
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m44
0
infinite
0
--
RasGRP1
--
e43
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
ca2+:RasGRP1
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m47
0
infinite
0
--
--
e45
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiMembrane
--
--
--
csml-variable:Double
m48
0
infinite
0
--
--
e46
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiLumen
--
--
--
csml-variable:Double
m49
0
infinite
0
--
--
e47
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiTransFace
--
--
--
csml-variable:Double
m63
0
infinite
0
--
--
e48
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiApparatus
--
--
--
csml-variable:Double
m64
0
infinite
0
--
RasGRP1
--
e49
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
antigen Ig:MHC peptide
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
TCR:antigen Ig:MHC peptide
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
anti-CD3
--
e63
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m66
0
infinite
0
--
low affinity peptide
--
e64
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m67
0
infinite
0
--
calmodulin:(ca)4:calcineurin
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
calmodulin:(ca)4:calcineurin{active}
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
NFAT{p}
--
e67
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m70
0
infinite
0
--
CK1
--
e68
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m71
0
infinite
0
--
cyclosporin A
--
e69
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
notch ligand:notch
--
e70
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m73
0
infinite
0
--
calcipressin
--
e71
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m74
0
infinite
0
--
csml-variable:Double
m75
0
infinite
0
--
ca2+:STIM1
--
e73
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m76
0
infinite
0
--
ca2+:STIM2
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m77
0
infinite
0
--
ORAI1
--
e75
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m78
0
infinite
0
--
STIM1:ORAI1
--
e76
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
target genes
--
e77
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m80
0
infinite
0
--
NFAT:FOXP3
--
e78
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m81
0
infinite
0
--
csml-variable:Double
m82
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
csml-variable:Double
m83
0
infinite
0
--
TGF-beta
--
e81
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m84
0
infinite
0
--
SIS3
--
e82
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
Fc receptor
--
e83
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m86
0
infinite
0
--
antigen Ig:MHC peptide:Fc receptor
--
e84
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m87
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m2534*m5*0.1
nodelay
--
0
PMID: 18515054 CRAC channels open in response to a lengthy signaling cascade, initiated when immunoreceptors, such as T-cell and B-cell antigen receptors (TCR, BCR) as well as mast cell and NK cell Fc receptors, are bound by antigenic complexes (MHC?peptide and antigen?Ig).
p10
p10
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c29 : 1
stoichiometry:c28 : 1
m24*m290231*0.1
nodelay
--
0
PMID: 18515054, 17098202, 16036612 DAG production activates the Ras-mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) pathways, which in turn lead to the activation of the transcription factors AP-1 (a transcriptional complex formed by c-Jun and c-Fos) and NF¦ÊB.
p11
p11
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c32 : 1
stoichiometry:c31 : 1
m92*m290231*0.1
nodelay
--
0
PMID: 18515054, 17098202, 16036612 DAG production activates the Ras-mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) pathways, which in turn lead to the activation of the transcription factors AP-1 (a transcriptional complex formed by c-Jun and c-Fos) and NF¦ÊB.
p12
p12
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c35 : 1
stoichiometry:c34 : 1
m219*m25*0.1
nodelay
--
0
PMID: 18515054, 17098202, 16036612 DAG production activates the Ras-mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) pathways, which in turn lead to the activation of the transcription factors AP-1 (a transcriptional complex formed by c-Jun and c-Fos) and NF¦ÊB.
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c47 : 1
stoichiometry:c37 : 1
m2057*m1812*0.1
nodelay
--
0
PMID: 18515054, 17098202, 16036612 DAG production activates the Ras-mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) pathways, which in turn lead to the activation of the transcription factors AP-1 (a transcriptional complex formed by c-Jun and c-Fos) and NF¦ÊB.
p14
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c40 : 1
stoichiometry:c39 : 1
m29*m25*0.1
nodelay
--
0
PMID: 18515054, 17098202, 16036612 DAG production activates the Ras-mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) pathways, which in turn lead to the activation of the transcription factors AP-1 (a transcriptional complex formed by c-Jun and c-Fos) and NF¦ÊB.
p15
p15
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c43 : 1
stoichiometry:c42 : 1
m29*m1812*0.1
nodelay
--
0
PMID: 18515054, 17098202, 16036612 DAG production activates the Ras-mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) pathways, which in turn lead to the activation of the transcription factors AP-1 (a transcriptional complex formed by c-Jun and c-Fos) and NF¦ÊB.
p16
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c46 : 1
stoichiometry:c45 : 1
m2057*m25*0.1
nodelay
--
0
PMID: 18515054, 17098202, 16036612 DAG production activates the Ras-mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) pathways, which in turn lead to the activation of the transcription factors AP-1 (a transcriptional complex formed by c-Jun and c-Fos) and NF¦ÊB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c51 : 1
stoichiometry:c97 : 1
m21*m68*0.1
nodelay
--
0
PMID: 18515054 As a result, several Ca2+-dependent signaling proteins and their target transcription factors are activated, including the phosphatase calcineurin and its target nuclear factor of activated T cells (NFATs), Ca2+-calmodulin-dependent kinase (CaMK) and its target cyclic-AMP-responsive-element-binding protein (CREB), myocyte enhancer factor 2 (MEF2) which is acted upon by both the calcineurin and CaMK pathways, and nuclear factor kappa B (NF¦ÊB). PMID: 18515054 An increase in [Ca2+]i results in binding of Ca2+-calmodulin to calcineurin and activation of its phosphatase activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c98 : 1
m32*0.1
nodelay
--
0
PMID: 18515054, 12975316 Dephosphorylation of cytoplasmic NFAT proteins by calcineurin unmasks the nuclear localization sequence and then NFAT proteins translocate into nucleus.
p2
p2
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c6 : 1
stoichiometry:c5 : 1
m123*m6*0.1
nodelay
--
0
PMID: 18515054 The binding of antigen/MHC complexes to T-cell receptor (TCR) triggers the activation of protein tyrosine kinases, such as LCK and ZAP70, which eventually results in tyrosine phosphorylation and activation of PLC-¦Ã1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c59 : 1
stoichiometry:c58 : 1
m33*m21*0.1
nodelay
--
0
PMID: 18515054 As a result, several Ca2+-dependent signaling proteins and their target transcription factors are activated, including the phosphatase calcineurin and its target nuclear factor of activated T cells (NFATs), Ca2+-calmodulin-dependent kinase (CaMK) and its target cyclic-AMP-responsive-element-binding protein (CREB), myocyte enhancer factor 2 (MEF2) which is acted upon by both the calcineurin and CaMK pathways, and nuclear factor kappa B (NF¦ÊB).
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c62 : 1
stoichiometry:c61 : 1
m2057*m34*0.1
nodelay
--
0
PMID: 18515054 As a result, several Ca2+-dependent signaling proteins and their target transcription factors are activated, including the phosphatase calcineurin and its target nuclear factor of activated T cells (NFATs), Ca2+-calmodulin-dependent kinase (CaMK) and its target cyclic-AMP-responsive-element-binding protein (CREB), myocyte enhancer factor 2 (MEF2) which is acted upon by both the calcineurin and CaMK pathways, and nuclear factor kappa B (NF¦ÊB).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c65 : 1
stoichiometry:c64 : 1
m35*m34*0.1
nodelay
--
0
PMID: 18515054 As a result, several Ca2+-dependent signaling proteins and their target transcription factors are activated, including the phosphatase calcineurin and its target nuclear factor of activated T cells (NFATs), Ca2+-calmodulin-dependent kinase (CaMK) and its target cyclic-AMP-responsive-element-binding protein (CREB), myocyte enhancer factor 2 (MEF2) which is acted upon by both the calcineurin and CaMK pathways, and nuclear factor kappa B (NF¦ÊB).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c68 : 1
stoichiometry:c67 : 1
m35*m69*0.1
nodelay
--
0
PMID: 18515054 As a result, several Ca2+-dependent signaling proteins and their target transcription factors are activated, including the phosphatase calcineurin and its target nuclear factor of activated T cells (NFATs), Ca2+-calmodulin-dependent kinase (CaMK) and its target cyclic-AMP-responsive-element-binding protein (CREB), myocyte enhancer factor 2 (MEF2) which is acted upon by both the calcineurin and CaMK pathways, and nuclear factor kappa B (NF¦ÊB).
p24
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c71 : 1
stoichiometry:c70 : 1
m29*m21*0.1
nodelay
--
0
PMID: 18515054 As a result, several Ca2+-dependent signaling proteins and their target transcription factors are activated, including the phosphatase calcineurin and its target nuclear factor of activated T cells (NFATs), Ca2+-calmodulin-dependent kinase (CaMK) and its target cyclic-AMP-responsive-element-binding protein (CREB), myocyte enhancer factor 2 (MEF2) which is acted upon by both the calcineurin and CaMK pathways, and nuclear factor kappa B (NF¦ÊB).
p25
p25
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c74 : 1
stoichiometry:c76 : 1
stoichiometry:c75 : 1
stoichiometry:c73 : 1
m37*m46*m221*m31*0.1
nodelay
--
0
PMID: 18515054, 12975316, 15928679 A notable example of such integration involves the formation of a cooperative NFAT:Fos:Jun complex on DNA, which drives the transcription of a large number of activation-associated genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m38*0.1
nodelay
--
0
PMID: 18515054, 12975316, 15928679 A notable example of such integration involves the formation of a cooperative NFAT:Fos:Jun complex on DNA, which drives the transcription of a large number of activation-associated genes.
p27
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c83 : 1
stoichiometry:c80 : 1
m41*m43*0.1
nodelay
--
0
PMID: 18515054, 11988768 Ras is activated by Ras guanine nucleotide exchange factor (RasGEF) and inactivated by RasGAPs, including GAP1 and Ca2+-activated CAPRI.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m45*m21*0.1
nodelay
--
0
PMID: 18515054, 9582122 RasGRP1 has a DAG-binding C1 domain and a pair of EF-hand motifs that bind to Ca2+ directly.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c89 : 1
stoichiometry:c88 : 1
m45*m66*0.1
nodelay
--
0
PMID: 18515054, 12845332, 17086201 RasGRP1 localizes in the cytoplasm of resting T cells and translocates to the Golgi apparatus in response to weak stimulation, such as with soluble anti-CD3 antibodies or with low-affinity peptides that induce positive selection of thymocytes.
p3
p3
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c9 : 1
stoichiometry:c8 : 1
m2529*m11*0.1
nodelay
--
0
PMID: 18515054 The binding of antigen/MHC complexes to T-cell receptor (TCR) triggers the activation of protein tyrosine kinases, such as LCK and ZAP70, which eventually results in tyrosine phosphorylation and activation of PLC-¦Ã1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c92 : 1
stoichiometry:c91 : 1
m45*m67*0.1
nodelay
--
0
PMID: 18515054, 12845332, 17086201 RasGRP1 localizes in the cytoplasm of resting T cells and translocates to the Golgi apparatus in response to weak stimulation, such as with soluble anti-CD3 antibodies or with low-affinity peptides that induce positive selection of thymocytes.
p31
p31
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c96 : 1
stoichiometry:c95 : 1
m1665*m1676*m21*0.1
nodelay
--
0
PMID: 18515054 An increase in [Ca2+]i results in binding of Ca2+-calmodulin to calcineurin and activation of its phosphatase activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c55 : 1
stoichiometry:c54 : 1
m30*m69*0.1
nodelay
--
0
PMID: 18515054 As a result, several Ca2+-dependent signaling proteins and their target transcription factors are activated, including the phosphatase calcineurin and its target nuclear factor of activated T cells (NFATs), Ca2+-calmodulin-dependent kinase (CaMK) and its target cyclic-AMP-responsive-element-binding protein (CREB), myocyte enhancer factor 2 (MEF2) which is acted upon by both the calcineurin and CaMK pathways, and nuclear factor kappa B (NF¦ÊB). PMID: 18515054, 12975316 Dephosphorylation of cytoplasmic NFAT proteins by calcineurin unmasks the nuclear localization sequence and then NFAT proteins translocate into nucleus.
p33
p33
cso30:i:ME_Phosphorylation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c101 : 1
stoichiometry:c116 : 1
stoichiometry:c100 : 1
m31*m1853*m21*0.1
nodelay
--
0
PMID: 18515054, 11030334, 15121840, 16511445 NFAT-driven gene expression is highly dependent on sustained Ca2+ influx and calcineurin activity, because a decrease in intracellular Ca2+ levels or treatment with the calcineurin inhibitor cyclosporin A results in the immediate export of NFAT from nucleus by NFAT kinases, which include glycogen synthase kinase 3 (GSK3), casein kinase 1 (CK1), and dual-specificity tyrosine-phosphorylation regulated kinases (DYRK1 and DYRK2).
p34
p34
cso30:i:ME_Phosphorylation
cso30:i:CC_NuclearChromosome
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c104 : 1
stoichiometry:c115 : 1
stoichiometry:c103 : 1
m31*m71*m21*0.1
nodelay
--
0
PMID: 18515054, 11030334, 15121840, 16511445 NFAT-driven gene expression is highly dependent on sustained Ca2+ influx and calcineurin activity, because a decrease in intracellular Ca2+ levels or treatment with the calcineurin inhibitor cyclosporin A results in the immediate export of NFAT from nucleus by NFAT kinases, which include glycogen synthase kinase 3 (GSK3), casein kinase 1 (CK1), and dual-specificity tyrosine-phosphorylation regulated kinases (DYRK1 and DYRK2).
p35
p35
cso30:i:ME_Phosphorylation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c109 : 1
stoichiometry:c113 : 1
stoichiometry:c106 : 1
m31*m15070*m21*0.1
nodelay
--
0
PMID: 18515054, 11030334, 15121840, 16511445 NFAT-driven gene expression is highly dependent on sustained Ca2+ influx and calcineurin activity, because a decrease in intracellular Ca2+ levels or treatment with the calcineurin inhibitor cyclosporin A results in the immediate export of NFAT from nucleus by NFAT kinases, which include glycogen synthase kinase 3 (GSK3), casein kinase 1 (CK1), and dual-specificity tyrosine-phosphorylation regulated kinases (DYRK1 and DYRK2).
p36
p36
cso30:i:ME_Phosphorylation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c110 : 1
stoichiometry:c114 : 1
stoichiometry:c108 : 1
m31*m44249*m21*0.1
nodelay
--
0
PMID: 18515054, 11030334, 15121840, 16511445 NFAT-driven gene expression is highly dependent on sustained Ca2+ influx and calcineurin activity, because a decrease in intracellular Ca2+ levels or treatment with the calcineurin inhibitor cyclosporin A results in the immediate export of NFAT from nucleus by NFAT kinases, which include glycogen synthase kinase 3 (GSK3), casein kinase 1 (CK1), and dual-specificity tyrosine-phosphorylation regulated kinases (DYRK1 and DYRK2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c117 : 1
stoichiometry:c112 : 1
m70*m72*0.1
nodelay
--
0
PMID: 18515054, 11030334, 15121840, 16511445 NFAT-driven gene expression is highly dependent on sustained Ca2+ influx and calcineurin activity, because a decrease in intracellular Ca2+ levels or treatment with the calcineurin inhibitor cyclosporin A results in the immediate export of NFAT from nucleus by NFAT kinases, which include glycogen synthase kinase 3 (GSK3), casein kinase 1 (CK1), and dual-specificity tyrosine-phosphorylation regulated kinases (DYRK1 and DYRK2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c122 : 1
stoichiometry:c118 : 1
m74*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c120 : 1
1.0*0.1
nodelay
--
0
PMID: 18515054, 15866158 Notch signaling increases calcineurin/NFAT activity by downregulating calcipressin, an endogenous calcineurin inhibitor.
p4
p4
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c16 : 1
stoichiometry:c11 : 1
m2395*m13*0.1
nodelay
--
0
PMID: 18515054 The binding of antigen/MHC complexes to T-cell receptor (TCR) triggers the activation of protein tyrosine kinases, such as LCK and ZAP70, which eventually results in tyrosine phosphorylation and activation of PLC-¦Ã1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c123 : 1
stoichiometry:c124 : 1
stoichiometry:c125 : 1
m20*m37358*0.1
nodelay
--
0
PMID: 18515054, 17434311, 15866891, 16005298 The first EF hand of each pair binds Ca2+ with low affinity matched to the high concentration of Ca2+ in the ER.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c127 : 1
stoichiometry:c128 : 1
m20*m41059*0.1
nodelay
--
0
PMID: 18515054, 17434311, 15866891, 16005298 The first EF hand of each pair binds Ca2+ with low affinity matched to the high concentration of Ca2+ in the ER.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c130 : 1
stoichiometry:c131 : 1
m76*0.1
nodelay
--
0
PMID: 18515054 After Ca2+ dissociates from the EF hands, STIM proteins aggregate into small clusters (¡Æpuncta¡Ç) in the ER membrane and trigger store-operated Ca2+ entry via the CRAC channel, ORAI1.
p43
p43
cso30:i:ME_IonTransportThroughIonChannel
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c133 : 1
m23*m78*m37358*0.1
nodelay
--
0
PMID: 18515054 After Ca2+ dissociates from the EF hands, STIM proteins aggregate into small clusters (¡Æpuncta¡Ç) in the ER membrane and trigger store-operated Ca2+ entry via the CRAC channel, ORAI1.
p44
p44
cso30:i:ME_Colocalization
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c137 : 1
stoichiometry:c138 : 1
m37358*m78*0.1
nodelay
--
0
PMID: 18515054, 17517596, 17045966, 16966422 The STIM1 clusters preferentially localize to sites of ER?plasma membrane apposition and colocalize partially with clusters of ORAI1.
p45
p45
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c140 : 1
m28*0.1
nodelay
--
0
PMID: 18515054, 12975316, 11244045 In contrast to NFAT, NF¦ÊB is selectively activated by a large transient increase of Ca2+ concentration and activates target gene expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c141 : 1
stoichiometry:c143 : 1
m20050*m31*0.1
nodelay
--
0
PMID: 18515054, 16873067 Foxp3 can also physically interact with NFAT, and this complex regulates the suppressive function of Foxp3-expressing T cells in a mouse model of autoimmune diabetes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c145 : 1
stoichiometry:c146 : 1
m78*m37358*0.1
nodelay
--
0
PMID: 18515054, 18187424 A coiled-coil domain in the cytoplasmic region of STIM1 is crucial for puncta formation and SOCE, and this region has been suggested to interact directly with a coiled-coil domain at the C-terminus of ORAI1, both in cell-free systems and by FRET after store depletion in cells.
p48
p48
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c149 : 1
stoichiometry:c151 : 1
stoichiometry:c150 : 1
m82*m2276*m31*m84*0.1
nodelay
--
0
PMID: 18515054 Smad3 binds to a Foxp3 distal enhancer early during TGF¦Â treatment, whereas NFAT binding to the 5¡ì-enhancer occurs at later times, which suggests that NFAT is responsible for maintaining Foxp3 expression.
p49
p49
cso30:i:ME_Transcription
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c156 : 1
stoichiometry:c158 : 1
stoichiometry:c160 : 1
stoichiometry:c152 : 1
m83*m84*0.1
nodelay
--
0
PMID: 18515054, 16517728, 18157133 Foxp3 expression in activated, TGF¦Â-treated T cells is blocked by the treatment with either cyclosporin A or the Smad3 inhibitor SIS3.
p5
p5
cso30:i:ME_Hydrolysis
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c15 : 1
stoichiometry:c12 : 1
stoichiometry:c13 : 1
m290229*m16647*0.1
nodelay
--
0
PMID: 18515054 PLC-¦Ã1 hydrolyzes the membrane phospholipid PIP2 to IP3 and DAG.
p50
p50
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c157 : 1
stoichiometry:c159 : 1
stoichiometry:c161 : 1
stoichiometry:c155 : 1
m94442*m84*0.1
nodelay
--
0
PMID: 18515054, 16517728, 18157133 Foxp3 expression in activated, TGF¦Â-treated T cells is blocked by the treatment with either cyclosporin A or the Smad3 inhibitor SIS3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
stoichiometry:c164 : 1
m2450*m5*0.1
nodelay
--
0
PMID: 18515054 CRAC channels open in response to a lengthy signaling cascade, initiated when immunoreceptors, such as T-cell and B-cell antigen receptors (TCR, BCR) as well as mast cell and NK cell Fc receptors, are bound by antigenic complexes (MHC?peptide and antigen?Ig).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c165 : 1
stoichiometry:c167 : 1
stoichiometry:c166 : 1
m86*m5*0.1
nodelay
--
0
PMID: 18515054 CRAC channels open in response to a lengthy signaling cascade, initiated when immunoreceptors, such as T-cell and B-cell antigen receptors (TCR, BCR) as well as mast cell and NK cell Fc receptors, are bound by antigenic complexes (MHC?peptide and antigen?Ig).
p6
p6
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m290230*m1719*0.1
nodelay
--
0
PMID: 18515054 IP3 opens IP3 receptors (IP3R), which permits Ca2+ efflux from ER Ca2+ stores. PMID: 18515054 IP3 binds to IP3 receptors in the ER membrane and causes the release of ER Ca2+ stores
p8
p8
cso30:i:ME_IonTransportThroughIonChannel
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c20 : 1
stoichiometry:c22 : 1
m20*m3862*0.1
nodelay
--
0
PMID: 18515054 IP3 opens IP3 receptors (IP3R), which permits Ca2+ efflux from ER Ca2+ stores.
p9
p9
cso30:i:ME_IonTransportThroughIonChannel
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c26 : 1
stoichiometry:c25 : 1
m23*m22*0.1
nodelay
--
0
PMID: 18515054 In turn, ER store depletion opens store-operated CRAC channels, which permit sustained Ca2+ influx into the cell
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--